Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiac diseases, with a prevalence of ∼0.2%. The disease affects all age groups, with marked clinical heterogeneity, ranging from a normal life span without symptoms to poor outcomes such as sudden cardiac death (SCD), advanced heart failure, or stroke.